Jpmorgan Chase & Co »

Spero Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $346 236 1.47
2023-09-30 $286 236 1.21
2023-06-30 $342 236 1.45
2023-03-31 $0 236 0.00
2022-12-31 $0 236 0.00
2022-06-30 $999 1.3k 0.78
2022-03-31 $706k 81k 8.69
2021-12-31 $1.6M 97k 16.12
2021-03-31 $1.0M 69k 14.74
2020-12-31 $1.4M 74k 19.39
2020-09-30 $897k 90k 9.98
2020-06-30 $1.3M 100k 13.53
2020-03-31 $634k 78k 8.12
2019-12-31 $0 133k 0.00
2019-09-30 $1.8M 167k 10.60
2019-06-30 $1.8M 164k 11.11
2019-03-31 $1.9M 151k 12.81
2018-12-31 $1.1M 186k 6.15
2018-09-30 $1.9M 177k 10.51
2018-06-30 $2.0M 139k 14.67
2018-03-31 $3.7M 256k 14.25
2017-12-31 $15k 1.3k 11.53